1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Late Stage Chronic Kidney Disease Drugs Market – By Product Type

1.3.2 North America Late Stage Chronic Kidney Disease Drugs Market – By Indication

1.3.3 North America Late Stage Chronic Kidney Disease Drugs Market – By Distribution Channel

1.3.4 North America Late Stage Chronic Kidney Disease Drugs Market – By Country

2. Late Stage Chronic Kidney Disease Drugs Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Late Stage Chronic Kidney Disease Drugs Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.3 Expert Opinion

5. Late Stage Chronic Kidney Disease Drugs Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 High Prevalence of Diseases Leading to Chronic Kidney Diseases

5.1.2 Favourable Reimbursement Policy for the Late Stage Chronic Kidney Disease Drugs

5.2 Market Restraints

5.2.1 Delay in the Diagnosis of Chronic Kidney Disease

5.3 Market Opportunities

5.3.1 Introduction of New Late Stage Chronic Kidney Disease Drugs

5.4 Future Trends

5.4.1 Introduction of New Preclinical Models to Improve Target Validation and Understand Disease Development

5.5 Impact Analysis

6. Late Stage Chronic Kidney Disease Drugs Market – North America Analysis

6.1 North America Late Stage Chronic Kidney Disease Drugs Market Revenue Forecast and Analysis

7. Late Stage Chronic Kidney Disease Drugs Market Analysis – By Product Type

7.1 Overview

7.2 Late Stage Chronic Kidney Disease Drugs Market Revenue Share, by Late Stage Chronic Kidney Disease Drugs by Product Type (2019 and 2027)

7.3 Calcimimetics

7.3.1 Overview

7.3.2 Calcimimetics: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

7.4 Vitamin D

7.4.1 Overview

7.4.2 Vitamin D: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

7.5 Potassium Binders

7.5.1 Overview

7.5.2 Potassium Binders: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

7.6 Calcium-Based Phosphate Binders

7.6.1 Calcium-Based Phosphate Binders: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

7.7 Others

7.7.1 Others: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

8. Late Stage Chronic Kidney Disease Drugs Market Analysis by Indication

8.1 Overview

8.2 Late Stage Chronic Kidney Disease Drugs Market Revenue Share, by Indication (2019 and 2027)

8.3 Late Stage Chronic Kidney Disease Induced Hyperparathyroidism

8.3.1 Overview

8.3.2 Late Stage Chronic Kidney Disease Induced Hyperparathyroidism: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Late Stage Chronic Kidney Disease Induced Hyperphosphatemia

8.4.1 Overview

8.4.2 Late Stage Chronic Kidney Disease Induced Hyperphosphatemia: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Late Stage Chronic Kidney Disease Induced Hyperkalemia

8.5.1 Overview

8.5.2 Late Stage Chronic Kidney Disease Induced Hyperkalemia: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9. Late Stage Chronic Kidney Disease Drugs Market Analysis by Distribution Channel

9.1 Overview

9.2 Late Stage Chronic Kidney Disease Drugs Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3 Hospital Pharmacies

9.3.1 Overview

9.3.2 Hospital Pharmacies: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Online Pharmacies

9.4.1 Overview

9.4.2 Online Pharmacies: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Retail Pharmacies

9.5.1 Overview

9.5.2 Retail Pharmacies Segment: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

10. Late Stage Chronic Kidney Disease Drugs Market Analysis and Forecasts To 2027 – North America Analysis

10.1 North America: Late Stage Chronic Kidney Disease Drugs Market

10.1.1 Overview

10.1.2 North America: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)

10.1.3 North America: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

10.1.4 North America: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)

10.1.5 North America: Late Stage Chronic Kidney Disease Drugs Market, By Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.6 North America: Late Stage Chronic Kidney Disease Drugs Market, by Country, 2019 & 2027 (%)

10.1.7 US: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1 US: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2 US: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.3 US: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)

10.1.7.4 US: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.8 Canada: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1 Canada: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2 Canada: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.3 Canada: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)

10.1.8.4 Canada: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.9 Mexico: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1 Mexico: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2 Mexico: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3 Mexico: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)

10.1.9.4 Mexico: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on North America Late Stage Chronic Kidney Disease Drugs Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

12.1 AbbVie Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Amgen

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 AstraZeneca

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Sanofi

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Kyowa Kirin Co., Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Takeda Pharmaceutical Company Limited

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Astellas Pharma Inc.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Bayer AG

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Vifor Pharma Management Ltd.

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Akebia Therapeutics, Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 Glossary of Terms

LIST OF TABLES

Table 1. North America: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 2. North America: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 3. North America: Late Stage Chronic Kidney Disease Drugs Market, By Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 4. US: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 5. US: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 6. US: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7. Canada: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 8. Canada: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 9. Canada: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 10. Mexico: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 11. Mexico: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 12. Mexico: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13. Glossary of Terms, Late Stage Chronic Kidney Disease Drugs Market

LIST OF FIGURES

Figure 1. Late Stage Chronic Kidney Disease Drugs Market Segmentation

Figure 2. Late Stage Chronic Kidney Disease Drugs Market – By Geography

Figure 3. North America Late Stage Chronic Kidney Disease Drugs Market Overview

Figure 4. Calcimimetics Segment Held Largest Share of Late Stage Chronic Kidney Disease Drugs Market

Figure 5. North America Late Stage Chronic Kidney Disease Drugs Market- Leading Country Markets (US$ Million)

Figure 6. North America PEST Analysis

Figure 7. Late Stage Chronic Kidney Disease Drugs Market Impact Analysis of Driver and Restraints

Figure 8. North America Late Stage Chronic Kidney Disease Drugs Market – Revenue Forecast and Analysis – 2019- 2027

Figure 9. Late Stage Chronic Kidney Disease Drugs Market Revenue Share, by Late Stage Chronic Kidney Disease Drugs by Product Type (2019 and 2027)

Figure 10. Calcimimetics: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11. Vitamin D: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12. Potassium Binders: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13. Calcium-Based Phosphate Binders: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14. Others: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15. Late Stage Chronic Kidney Disease Drugs Market Revenue Share, by Indication (2019 and 2027)

Figure 16. Late Stage Chronic Kidney Disease Induced Hyperparathyroidism: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17. Late Stage Chronic Kidney Disease Induced Hyperphosphatemia: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18. Late Stage Chronic Kidney Disease Induced Hyperkalemia: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19. Late Stage Chronic Kidney Disease Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 20. Hospital Pharmacies: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21. Online Pharmacies: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22. Retail Pharmacies: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23. North America: Late Stage Chronic Kidney Disease Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 24. North America: Late Stage Chronic Kidney Disease Drugs Market Revenue and Forecast to 2027 (USD Million)

Figure 25. North America: Late Stage Chronic Kidney Disease Drugs Market, by Country, 2019 & 2027 (%)

Figure 26. US: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 27. Canada: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 28. Mexico: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 29. Impact of COVID-19 Pandemic on Late Stage Chronic Kidney Disease Drugs Market in North American Countries